/ Syngene International Slips Over 4% ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Friday, 28 April 2017

Syngene International Limited on Friday is trading lower by 4.5% on the BSE. The company on Thursday announced that the board of directors in their meeting held on April 27, 2017, have recommended a final dividend at a rate of 10% i.e. Re 1.00 per equity share for the financial year ended March 31, 2017.

The dividend is subject to shareholders' approval at the ensuing annual general meeting.

The stock has delivered nearly 30% returns in a period of one year, underperforming the BSE Mid cap and outperforming the BSE Healthcare indices over the same time span.

Syngene International Limited is a contract research company. The company is engaged in providing contract research and manufacturing services in early-stage drug discovery and development, to pharmaceutical and biotechnology companies.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717